Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid

Quantitative and qualitative analysis

Suk Keu Yeom, Jae Ho Byun, Hye Jin Kim, Seong Ho Park, Namkug Kim, Yong Moon Shin, Pyo Nyun Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To evaluate the image findings of focal fat deposition (FFD) in the liver on gadobenate dimeglumine (Gd-BOPTA)- and gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI, particularly during the hepatobiliary phase (HBP), and the relationship between relative enhancement (RE) and fat signal fraction (FSF) of FFD. Subjects and Methods: Twenty-one patients with 27 FFDs (mean diameter, 21.9mm), which showed low signal intensity on opposed-phase compared with in-phase MRI, were retrospectively evaluated. RE of the liver (REliver) and FFD (REFFD) and liver-to-lesion contrast-to-noise ratio (CNR) of FFD were measured on dynamic phases and HBP images with fat-saturated in-phase gradient-echo sequence. The FSF of each FFD was measured on in- and opposed-phase dual gradient-echo images. We qualitatively analyzed imaging findings of FFDs, including signal intensity, shape, margin, and homogeneity on HBP images, and enhancement pattern during dynamic phases. The correlations between REFFD and FSF and between CNR and FSF on HBP images were evaluated using Pearson's correlation tests and a simple linear regression model. Results: There were no significant differences between REFFD and REliver in dynamic phases and HBP, regardless of contrast agents (p≥0.075). On HBP images, CNR (p=0.008) but not REFFD (p=0.122) was significantly correlated with FSF of FFDs (mean FSF, 19%). On HBP images, 21 of the 27 (77.8%) FFDs were hypointense, and 17 (63%) were homogeneous. Of the 21 hypointense FFDs, 12 (57.1%) had an ovoid shape and 11 (52.4%) were well margined. Although the 27 FFDs showed various enhancement patterns, 17 (63%) showed no enhancement. Conclusion: Most FFDs appeared as hypointense lesions on Gd-BOPTA- and Gd-EOB-DTPA-enhanced MRI during HBP, with various enhancement patterns during dynamic contrast-enhanced phases. REFFD on HBP images was not significantly correlated with FSF of low grade FFDs.

Original languageEnglish
Pages (from-to)911-917
Number of pages7
JournalMagnetic Resonance Imaging
Volume31
Issue number6
DOIs
Publication statusPublished - 2013 Jul 1
Externally publishedYes

Fingerprint

Oils and fats
Liver
Magnetic resonance imaging
Fats
Acids
gadolinium ethoxybenzyl DTPA
gadobenic acid
Noise
Linear Models
Image Enhancement
Signal-To-Noise Ratio
Linear regression
Contrast Media

Keywords

  • Focal fat deposition
  • Gd-BOPTA
  • Gd-EOB-DTPA
  • Liver
  • MRI

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging

Cite this

Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid : Quantitative and qualitative analysis. / Yeom, Suk Keu; Byun, Jae Ho; Kim, Hye Jin; Park, Seong Ho; Kim, Namkug; Shin, Yong Moon; Kim, Pyo Nyun.

In: Magnetic Resonance Imaging, Vol. 31, No. 6, 01.07.2013, p. 911-917.

Research output: Contribution to journalArticle

Yeom, Suk Keu ; Byun, Jae Ho ; Kim, Hye Jin ; Park, Seong Ho ; Kim, Namkug ; Shin, Yong Moon ; Kim, Pyo Nyun. / Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid : Quantitative and qualitative analysis. In: Magnetic Resonance Imaging. 2013 ; Vol. 31, No. 6. pp. 911-917.
@article{8353147843f346938b4d6a8154dc4b80,
title = "Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis",
abstract = "Objective: To evaluate the image findings of focal fat deposition (FFD) in the liver on gadobenate dimeglumine (Gd-BOPTA)- and gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI, particularly during the hepatobiliary phase (HBP), and the relationship between relative enhancement (RE) and fat signal fraction (FSF) of FFD. Subjects and Methods: Twenty-one patients with 27 FFDs (mean diameter, 21.9mm), which showed low signal intensity on opposed-phase compared with in-phase MRI, were retrospectively evaluated. RE of the liver (REliver) and FFD (REFFD) and liver-to-lesion contrast-to-noise ratio (CNR) of FFD were measured on dynamic phases and HBP images with fat-saturated in-phase gradient-echo sequence. The FSF of each FFD was measured on in- and opposed-phase dual gradient-echo images. We qualitatively analyzed imaging findings of FFDs, including signal intensity, shape, margin, and homogeneity on HBP images, and enhancement pattern during dynamic phases. The correlations between REFFD and FSF and between CNR and FSF on HBP images were evaluated using Pearson's correlation tests and a simple linear regression model. Results: There were no significant differences between REFFD and REliver in dynamic phases and HBP, regardless of contrast agents (p≥0.075). On HBP images, CNR (p=0.008) but not REFFD (p=0.122) was significantly correlated with FSF of FFDs (mean FSF, 19{\%}). On HBP images, 21 of the 27 (77.8{\%}) FFDs were hypointense, and 17 (63{\%}) were homogeneous. Of the 21 hypointense FFDs, 12 (57.1{\%}) had an ovoid shape and 11 (52.4{\%}) were well margined. Although the 27 FFDs showed various enhancement patterns, 17 (63{\%}) showed no enhancement. Conclusion: Most FFDs appeared as hypointense lesions on Gd-BOPTA- and Gd-EOB-DTPA-enhanced MRI during HBP, with various enhancement patterns during dynamic contrast-enhanced phases. REFFD on HBP images was not significantly correlated with FSF of low grade FFDs.",
keywords = "Focal fat deposition, Gd-BOPTA, Gd-EOB-DTPA, Liver, MRI",
author = "Yeom, {Suk Keu} and Byun, {Jae Ho} and Kim, {Hye Jin} and Park, {Seong Ho} and Namkug Kim and Shin, {Yong Moon} and Kim, {Pyo Nyun}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.mri.2013.02.002",
language = "English",
volume = "31",
pages = "911--917",
journal = "Magnetic Resonance Imaging",
issn = "0730-725X",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid

T2 - Quantitative and qualitative analysis

AU - Yeom, Suk Keu

AU - Byun, Jae Ho

AU - Kim, Hye Jin

AU - Park, Seong Ho

AU - Kim, Namkug

AU - Shin, Yong Moon

AU - Kim, Pyo Nyun

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Objective: To evaluate the image findings of focal fat deposition (FFD) in the liver on gadobenate dimeglumine (Gd-BOPTA)- and gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI, particularly during the hepatobiliary phase (HBP), and the relationship between relative enhancement (RE) and fat signal fraction (FSF) of FFD. Subjects and Methods: Twenty-one patients with 27 FFDs (mean diameter, 21.9mm), which showed low signal intensity on opposed-phase compared with in-phase MRI, were retrospectively evaluated. RE of the liver (REliver) and FFD (REFFD) and liver-to-lesion contrast-to-noise ratio (CNR) of FFD were measured on dynamic phases and HBP images with fat-saturated in-phase gradient-echo sequence. The FSF of each FFD was measured on in- and opposed-phase dual gradient-echo images. We qualitatively analyzed imaging findings of FFDs, including signal intensity, shape, margin, and homogeneity on HBP images, and enhancement pattern during dynamic phases. The correlations between REFFD and FSF and between CNR and FSF on HBP images were evaluated using Pearson's correlation tests and a simple linear regression model. Results: There were no significant differences between REFFD and REliver in dynamic phases and HBP, regardless of contrast agents (p≥0.075). On HBP images, CNR (p=0.008) but not REFFD (p=0.122) was significantly correlated with FSF of FFDs (mean FSF, 19%). On HBP images, 21 of the 27 (77.8%) FFDs were hypointense, and 17 (63%) were homogeneous. Of the 21 hypointense FFDs, 12 (57.1%) had an ovoid shape and 11 (52.4%) were well margined. Although the 27 FFDs showed various enhancement patterns, 17 (63%) showed no enhancement. Conclusion: Most FFDs appeared as hypointense lesions on Gd-BOPTA- and Gd-EOB-DTPA-enhanced MRI during HBP, with various enhancement patterns during dynamic contrast-enhanced phases. REFFD on HBP images was not significantly correlated with FSF of low grade FFDs.

AB - Objective: To evaluate the image findings of focal fat deposition (FFD) in the liver on gadobenate dimeglumine (Gd-BOPTA)- and gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI, particularly during the hepatobiliary phase (HBP), and the relationship between relative enhancement (RE) and fat signal fraction (FSF) of FFD. Subjects and Methods: Twenty-one patients with 27 FFDs (mean diameter, 21.9mm), which showed low signal intensity on opposed-phase compared with in-phase MRI, were retrospectively evaluated. RE of the liver (REliver) and FFD (REFFD) and liver-to-lesion contrast-to-noise ratio (CNR) of FFD were measured on dynamic phases and HBP images with fat-saturated in-phase gradient-echo sequence. The FSF of each FFD was measured on in- and opposed-phase dual gradient-echo images. We qualitatively analyzed imaging findings of FFDs, including signal intensity, shape, margin, and homogeneity on HBP images, and enhancement pattern during dynamic phases. The correlations between REFFD and FSF and between CNR and FSF on HBP images were evaluated using Pearson's correlation tests and a simple linear regression model. Results: There were no significant differences between REFFD and REliver in dynamic phases and HBP, regardless of contrast agents (p≥0.075). On HBP images, CNR (p=0.008) but not REFFD (p=0.122) was significantly correlated with FSF of FFDs (mean FSF, 19%). On HBP images, 21 of the 27 (77.8%) FFDs were hypointense, and 17 (63%) were homogeneous. Of the 21 hypointense FFDs, 12 (57.1%) had an ovoid shape and 11 (52.4%) were well margined. Although the 27 FFDs showed various enhancement patterns, 17 (63%) showed no enhancement. Conclusion: Most FFDs appeared as hypointense lesions on Gd-BOPTA- and Gd-EOB-DTPA-enhanced MRI during HBP, with various enhancement patterns during dynamic contrast-enhanced phases. REFFD on HBP images was not significantly correlated with FSF of low grade FFDs.

KW - Focal fat deposition

KW - Gd-BOPTA

KW - Gd-EOB-DTPA

KW - Liver

KW - MRI

UR - http://www.scopus.com/inward/record.url?scp=84878625038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878625038&partnerID=8YFLogxK

U2 - 10.1016/j.mri.2013.02.002

DO - 10.1016/j.mri.2013.02.002

M3 - Article

VL - 31

SP - 911

EP - 917

JO - Magnetic Resonance Imaging

JF - Magnetic Resonance Imaging

SN - 0730-725X

IS - 6

ER -